Single Cell Analysis Market By Product (Consumables, Instruments), By Techniques (Flow Cytometry, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Mass Spectrometry, Others), By End User (Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Others), By Application (Oncology, Immunology, Neurology, Stem cell, Non-Invasive Prenatal Diagnosis, In-Vitro Fertilization (IVF), Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global single cell analysis market was valued at $2,641.5 million in 2021, and is projected to reach $13,616.76 million by 2031, registering a CAGR of 17.8% from 2022 to 2031.
Single-cell analysis (SCA) is essential in order to show population heterogeneity, identify minority sub-populations of interest, and learn about the particular traits of individual cells. Microfluidic systems are useful for manipulating single cells since they operate at a scale similar to cell diameter. A microfluidic array capable of quickly and deterministically trapping individual cells in densely packed microwells. This trapping array can be linked with multiple microfluidic sample processing units with variable flow rates for various single-cell studies because the single-cell trapping efficiency is dictated by the channel design rather than the flow rate. SCA is also commonly used in plant biology, prenatal diagnostics, microbiology, immunology, and neuroscience.
The major factors that drive the growth of the global single cell analysis market include technological advancement in single cell analysis and increase in R&D in pharmaceutical and biotechnology industry. In addition, growth in stem cell research, growing focus on personalized medicines and surge in prevalence of cancer further propel the market growth. However, high cost of single cell analysis products is expected to restrain the growth of the single cell analysis market during the forecast period. Conversely, high growth potential of single cell sequencing is anticipated to provide lucrative opportunities to the market players.
The single cell analysis market is segmented into product, application, techniques, end user and region. According to product, the market is categorized into consumables and instruments. By application, it is segregated into oncology, immunology, neurology, stem cell, non-invasive prenatal diagnosis, In-vitro fertilization, others. According to techniques, the market is categorized into flow cytometry, next generation sequencing, polymerase chain reaction, mass spectrometry and others. On the basis of end user, it is segmented into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include the Becton, Dickinson and Company, Danaher Corporation, Merck KGAA, QIAGEN N.V., Thermo Fisher Scientific, Inc., 10x Genomics, Illumina, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Sartorius AG, Takara Holdingsinc, Oxford Nanopore Technologies., Berkley Light INC., BGI Genomics Co.Ltd., Diasorin Group, Dolomite Bio, Standard Biotools.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the single cell analysis market analysis from 2021 to 2031 to identify the prevailing single cell analysis market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the single cell analysis market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global single cell analysis market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Consumables
Instruments
By Techniques
Flow Cytometry
Next Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Mass Spectrometry
Others
By End User
Academic and Research Laboratories
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Others
By Application
Oncology
Immunology
Neurology
Stem cell
Non-Invasive Prenatal Diagnosis
In-Vitro Fertilization (IVF)
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
10x Genomics
Agilent Technologies, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories
Danaher Corporation(Cytiva Life Sciences)
Illumina, Inc.
BERKLEY LIGHTS INC
BGI GENOMICS CO. LTD
DIASORIN GROUP (LUMINEX CORPORATION)
DOLOMITE BIO
MERCK KGAA
OXFORD NANAOPORE TECHNOLOGIES
QIAGEN N.V
Sartorius AG
STANDARD BIOTOOLS (Fluidigm Corporation)
TAKARA HOLDINGS INC
THERMO FISHER SCIENTIFIC, INC.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: SINGLE CELL ANALYSIS MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Consumables
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Instruments
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- CHAPTER 5: SINGLE CELL ANALYSIS MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Oncology
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Immunology
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Neurology
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Stem cell
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- 5.6 Non-Invasive Prenatal Diagnosis
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country
- 5.7 In-Vitro Fertilization (IVF)
- 5.7.1 Key market trends, growth factors and opportunities
- 5.7.2 Market size and forecast, by region
- 5.7.3 Market analysis by country
- 5.8 Others
- 5.8.1 Key market trends, growth factors and opportunities
- 5.8.2 Market size and forecast, by region
- 5.8.3 Market analysis by country
- CHAPTER 6: SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Flow Cytometry
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Next Generation Sequencing (NGS)
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Polymerase Chain Reaction (PCR)
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- 6.5 Mass Spectrometry
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
- 6.6 Others
- 6.6.1 Key market trends, growth factors and opportunities
- 6.6.2 Market size and forecast, by region
- 6.6.3 Market analysis by country
- CHAPTER 7: SINGLE CELL ANALYSIS MARKET, BY END USER
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Academic and Research Laboratories
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
- 7.3 Biotechnology and Pharmaceutical Companies
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
- 7.4 Hospitals and Diagnostic Laboratories
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
- 7.5 Others
- 7.5.1 Key market trends, growth factors and opportunities
- 7.5.2 Market size and forecast, by region
- 7.5.3 Market analysis by country
- CHAPTER 8: SINGLE CELL ANALYSIS MARKET, BY REGION
- 8.1 Overview
- 8.1.1 Market size and forecast
- 8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Product
- 8.2.3 North America Market size and forecast, by Application
- 8.2.4 North America Market size and forecast, by Techniques
- 8.2.5 North America Market size and forecast, by End User
- 8.2.6 North America Market size and forecast, by country
- 8.2.6.1 U.S.
- 8.2.6.1.1 Market size and forecast, by Product
- 8.2.6.1.2 Market size and forecast, by Application
- 8.2.6.1.3 Market size and forecast, by Techniques
- 8.2.6.1.4 Market size and forecast, by End User
- 8.2.6.2 Canada
- 8.2.6.2.1 Market size and forecast, by Product
- 8.2.6.2.2 Market size and forecast, by Application
- 8.2.6.2.3 Market size and forecast, by Techniques
- 8.2.6.2.4 Market size and forecast, by End User
- 8.2.6.3 Mexico
- 8.2.6.3.1 Market size and forecast, by Product
- 8.2.6.3.2 Market size and forecast, by Application
- 8.2.6.3.3 Market size and forecast, by Techniques
- 8.2.6.3.4 Market size and forecast, by End User
- 8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Product
- 8.3.3 Europe Market size and forecast, by Application
- 8.3.4 Europe Market size and forecast, by Techniques
- 8.3.5 Europe Market size and forecast, by End User
- 8.3.6 Europe Market size and forecast, by country
- 8.3.6.1 Germany
- 8.3.6.1.1 Market size and forecast, by Product
- 8.3.6.1.2 Market size and forecast, by Application
- 8.3.6.1.3 Market size and forecast, by Techniques
- 8.3.6.1.4 Market size and forecast, by End User
- 8.3.6.2 France
- 8.3.6.2.1 Market size and forecast, by Product
- 8.3.6.2.2 Market size and forecast, by Application
- 8.3.6.2.3 Market size and forecast, by Techniques
- 8.3.6.2.4 Market size and forecast, by End User
- 8.3.6.3 U.K.
- 8.3.6.3.1 Market size and forecast, by Product
- 8.3.6.3.2 Market size and forecast, by Application
- 8.3.6.3.3 Market size and forecast, by Techniques
- 8.3.6.3.4 Market size and forecast, by End User
- 8.3.6.4 Italy
- 8.3.6.4.1 Market size and forecast, by Product
- 8.3.6.4.2 Market size and forecast, by Application
- 8.3.6.4.3 Market size and forecast, by Techniques
- 8.3.6.4.4 Market size and forecast, by End User
- 8.3.6.5 Spain
- 8.3.6.5.1 Market size and forecast, by Product
- 8.3.6.5.2 Market size and forecast, by Application
- 8.3.6.5.3 Market size and forecast, by Techniques
- 8.3.6.5.4 Market size and forecast, by End User
- 8.3.6.6 Rest of Europe
- 8.3.6.6.1 Market size and forecast, by Product
- 8.3.6.6.2 Market size and forecast, by Application
- 8.3.6.6.3 Market size and forecast, by Techniques
- 8.3.6.6.4 Market size and forecast, by End User
- 8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Product
- 8.4.3 Asia-Pacific Market size and forecast, by Application
- 8.4.4 Asia-Pacific Market size and forecast, by Techniques
- 8.4.5 Asia-Pacific Market size and forecast, by End User
- 8.4.6 Asia-Pacific Market size and forecast, by country
- 8.4.6.1 Japan
- 8.4.6.1.1 Market size and forecast, by Product
- 8.4.6.1.2 Market size and forecast, by Application
- 8.4.6.1.3 Market size and forecast, by Techniques
- 8.4.6.1.4 Market size and forecast, by End User
- 8.4.6.2 China
- 8.4.6.2.1 Market size and forecast, by Product
- 8.4.6.2.2 Market size and forecast, by Application
- 8.4.6.2.3 Market size and forecast, by Techniques
- 8.4.6.2.4 Market size and forecast, by End User
- 8.4.6.3 India
- 8.4.6.3.1 Market size and forecast, by Product
- 8.4.6.3.2 Market size and forecast, by Application
- 8.4.6.3.3 Market size and forecast, by Techniques
- 8.4.6.3.4 Market size and forecast, by End User
- 8.4.6.4 Australia
- 8.4.6.4.1 Market size and forecast, by Product
- 8.4.6.4.2 Market size and forecast, by Application
- 8.4.6.4.3 Market size and forecast, by Techniques
- 8.4.6.4.4 Market size and forecast, by End User
- 8.4.6.5 South Korea
- 8.4.6.5.1 Market size and forecast, by Product
- 8.4.6.5.2 Market size and forecast, by Application
- 8.4.6.5.3 Market size and forecast, by Techniques
- 8.4.6.5.4 Market size and forecast, by End User
- 8.4.6.6 Rest of Asia-Pacific
- 8.4.6.6.1 Market size and forecast, by Product
- 8.4.6.6.2 Market size and forecast, by Application
- 8.4.6.6.3 Market size and forecast, by Techniques
- 8.4.6.6.4 Market size and forecast, by End User
- 8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Product
- 8.5.3 LAMEA Market size and forecast, by Application
- 8.5.4 LAMEA Market size and forecast, by Techniques
- 8.5.5 LAMEA Market size and forecast, by End User
- 8.5.6 LAMEA Market size and forecast, by country
- 8.5.6.1 Brazil
- 8.5.6.1.1 Market size and forecast, by Product
- 8.5.6.1.2 Market size and forecast, by Application
- 8.5.6.1.3 Market size and forecast, by Techniques
- 8.5.6.1.4 Market size and forecast, by End User
- 8.5.6.2 Saudi Arabia
- 8.5.6.2.1 Market size and forecast, by Product
- 8.5.6.2.2 Market size and forecast, by Application
- 8.5.6.2.3 Market size and forecast, by Techniques
- 8.5.6.2.4 Market size and forecast, by End User
- 8.5.6.3 South Africa
- 8.5.6.3.1 Market size and forecast, by Product
- 8.5.6.3.2 Market size and forecast, by Application
- 8.5.6.3.3 Market size and forecast, by Techniques
- 8.5.6.3.4 Market size and forecast, by End User
- 8.5.6.4 Rest of LAMEA
- 8.5.6.4.1 Market size and forecast, by Product
- 8.5.6.4.2 Market size and forecast, by Application
- 8.5.6.4.3 Market size and forecast, by Techniques
- 8.5.6.4.4 Market size and forecast, by End User
- CHAPTER 9: COMPANY LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product Mapping of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Key developments
- CHAPTER 10: COMPANY PROFILES
- 10.1 10x Genomics
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
- 10.2 Agilent Technologies, Inc.
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
- 10.3 Becton, Dickinson and Company
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
- 10.4 Bio-Rad Laboratories
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
- 10.5 Danaher Corporation(Cytiva Life Sciences)
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
- 10.6 Illumina, Inc.
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
- 10.7 BERKLEY LIGHTS INC
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
- 10.8 BGI GENOMICS CO. LTD
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
- 10.9 DIASORIN GROUP (LUMINEX CORPORATION)
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
- 10.10 DOLOMITE BIO
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments
- 10.11 MERCK KGAA
- 10.11.1 Company overview
- 10.11.2 Company snapshot
- 10.11.3 Operating business segments
- 10.11.4 Product portfolio
- 10.11.5 Business performance
- 10.11.6 Key strategic moves and developments
- 10.12 OXFORD NANAOPORE TECHNOLOGIES
- 10.12.1 Company overview
- 10.12.2 Company snapshot
- 10.12.3 Operating business segments
- 10.12.4 Product portfolio
- 10.12.5 Business performance
- 10.12.6 Key strategic moves and developments
- 10.13 QIAGEN N.V
- 10.13.1 Company overview
- 10.13.2 Company snapshot
- 10.13.3 Operating business segments
- 10.13.4 Product portfolio
- 10.13.5 Business performance
- 10.13.6 Key strategic moves and developments
- 10.14 Sartorius AG
- 10.14.1 Company overview
- 10.14.2 Company snapshot
- 10.14.3 Operating business segments
- 10.14.4 Product portfolio
- 10.14.5 Business performance
- 10.14.6 Key strategic moves and developments
- 10.15 STANDARD BIOTOOLS (Fluidigm Corporation)
- 10.15.1 Company overview
- 10.15.2 Company snapshot
- 10.15.3 Operating business segments
- 10.15.4 Product portfolio
- 10.15.5 Business performance
- 10.15.6 Key strategic moves and developments
- 10.16 TAKARA HOLDINGS INC
- 10.16.1 Company overview
- 10.16.2 Company snapshot
- 10.16.3 Operating business segments
- 10.16.4 Product portfolio
- 10.16.5 Business performance
- 10.16.6 Key strategic moves and developments
- 10.17 THERMO FISHER SCIENTIFIC, INC.
- 10.17.1 Company overview
- 10.17.2 Company snapshot
- 10.17.3 Operating business segments
- 10.17.4 Product portfolio
- 10.17.5 Business performance
- 10.17.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 2. SINGLE CELL ANALYSIS MARKET SIZE, FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. SINGLE CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. SINGLE CELL ANALYSIS MARKET SIZE, FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. SINGLE CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. GLOBAL SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 7. SINGLE CELL ANALYSIS MARKET SIZE, FOR ONCOLOGY, BY REGION, 2021-2031 ($MILLION)
- TABLE 8. SINGLE CELL ANALYSIS MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 9. SINGLE CELL ANALYSIS MARKET SIZE, FOR IMMUNOLOGY, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. SINGLE CELL ANALYSIS MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. SINGLE CELL ANALYSIS MARKET SIZE, FOR NEUROLOGY, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. SINGLE CELL ANALYSIS MARKET FOR NEUROLOGY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 13. SINGLE CELL ANALYSIS MARKET SIZE, FOR STEM CELL, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. SINGLE CELL ANALYSIS MARKET FOR STEM CELL, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 15. SINGLE CELL ANALYSIS MARKET SIZE, FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY REGION, 2021-2031 ($MILLION)
- TABLE 16. SINGLE CELL ANALYSIS MARKET FOR NON-INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 17. SINGLE CELL ANALYSIS MARKET SIZE, FOR IN-VITRO FERTILIZATION (IVF), BY REGION, 2021-2031 ($MILLION)
- TABLE 18. SINGLE CELL ANALYSIS MARKET FOR IN-VITRO FERTILIZATION (IVF), BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 19. SINGLE CELL ANALYSIS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 20. SINGLE CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 21. GLOBAL SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 22. SINGLE CELL ANALYSIS MARKET SIZE, FOR FLOW CYTOMETRY, BY REGION, 2021-2031 ($MILLION)
- TABLE 23. SINGLE CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 24. SINGLE CELL ANALYSIS MARKET SIZE, FOR NEXT GENERATION SEQUENCING (NGS), BY REGION, 2021-2031 ($MILLION)
- TABLE 25. SINGLE CELL ANALYSIS MARKET FOR NEXT GENERATION SEQUENCING (NGS), BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 26. SINGLE CELL ANALYSIS MARKET SIZE, FOR POLYMERASE CHAIN REACTION (PCR), BY REGION, 2021-2031 ($MILLION)
- TABLE 27. SINGLE CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION (PCR), BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 28. SINGLE CELL ANALYSIS MARKET SIZE, FOR MASS SPECTROMETRY, BY REGION, 2021-2031 ($MILLION)
- TABLE 29. SINGLE CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 30. SINGLE CELL ANALYSIS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 31. SINGLE CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 32. GLOBAL SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 33. SINGLE CELL ANALYSIS MARKET SIZE, FOR ACADEMIC AND RESEARCH LABORATORIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 34. SINGLE CELL ANALYSIS MARKET FOR ACADEMIC AND RESEARCH LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 35. SINGLE CELL ANALYSIS MARKET SIZE, FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 36. SINGLE CELL ANALYSIS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 37. SINGLE CELL ANALYSIS MARKET SIZE, FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 38. SINGLE CELL ANALYSIS MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 39. SINGLE CELL ANALYSIS MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 40. SINGLE CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 41. SINGLE CELL ANALYSIS MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 42. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 43. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 44. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 45. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 46. NORTH AMERICA SINGLE CELL ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 47. U.S. SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 48. U.S. SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 49. U.S. SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 50. U.S. SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 51. CANADA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 52. CANADA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 53. CANADA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 54. CANADA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 55. MEXICO SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 56. MEXICO SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 57. MEXICO SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 58. MEXICO SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 59. EUROPE SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 60. EUROPE SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 61. EUROPE SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 62. EUROPE SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 63. EUROPE SINGLE CELL ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 64. GERMANY SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 65. GERMANY SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 66. GERMANY SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 67. GERMANY SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 68. FRANCE SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 69. FRANCE SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 70. FRANCE SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 71. FRANCE SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 72. U.K. SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 73. U.K. SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 74. U.K. SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 75. U.K. SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 76. ITALY SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 77. ITALY SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 78. ITALY SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 79. ITALY SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 80. SPAIN SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 81. SPAIN SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 82. SPAIN SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 83. SPAIN SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 84. REST OF EUROPE SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 85. REST OF EUROPE SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 86. REST OF EUROPE SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 87. REST OF EUROPE SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 88. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 89. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 90. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 91. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 92. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 93. JAPAN SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 94. JAPAN SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 95. JAPAN SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 96. JAPAN SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 97. CHINA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 98. CHINA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 99. CHINA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 100. CHINA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 101. INDIA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 102. INDIA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 103. INDIA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 104. INDIA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 105. AUSTRALIA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 106. AUSTRALIA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 107. AUSTRALIA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 108. AUSTRALIA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 109. SOUTH KOREA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 110. SOUTH KOREA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 111. SOUTH KOREA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 112. SOUTH KOREA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 113. REST OF ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 114. REST OF ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 115. REST OF ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 116. REST OF ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 117. LAMEA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 118. LAMEA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 119. LAMEA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 120. LAMEA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 121. LAMEA SINGLE CELL ANALYSIS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 122. BRAZIL SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 123. BRAZIL SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 124. BRAZIL SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 125. BRAZIL SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 126. SAUDI ARABIA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 127. SAUDI ARABIA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 128. SAUDI ARABIA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 129. SAUDI ARABIA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 130. SOUTH AFRICA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 131. SOUTH AFRICA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 132. SOUTH AFRICA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 133. SOUTH AFRICA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 134. REST OF LAMEA SINGLE CELL ANALYSIS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 135. REST OF LAMEA SINGLE CELL ANALYSIS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 136. REST OF LAMEA SINGLE CELL ANALYSIS MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
- TABLE 137. REST OF LAMEA SINGLE CELL ANALYSIS MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 138.10X GENOMICS: COMPANY SNAPSHOT
- TABLE 139.10X GENOMICS: OPERATING SEGMENTS
- TABLE 140.10X GENOMICS: PRODUCT PORTFOLIO
- TABLE 141.10X GENOMICS: NET SALES,
- TABLE 142.10X GENOMICS: KEY STRATERGIES
- TABLE 143.AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
- TABLE 144.AGILENT TECHNOLOGIES, INC.: OPERATING SEGMENTS
- TABLE 145.AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
- TABLE 146.AGILENT TECHNOLOGIES, INC.: NET SALES,
- TABLE 147.AGILENT TECHNOLOGIES, INC.: KEY STRATERGIES
- TABLE 148.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 149.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
- TABLE 150.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 151.BECTON, DICKINSON AND COMPANY: NET SALES,
- TABLE 152.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
- TABLE 153.BIO-RAD LABORATORIES: COMPANY SNAPSHOT
- TABLE 154.BIO-RAD LABORATORIES: OPERATING SEGMENTS
- TABLE 155.BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
- TABLE 156.BIO-RAD LABORATORIES: NET SALES,
- TABLE 157.BIO-RAD LABORATORIES: KEY STRATERGIES
- TABLE 158.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): COMPANY SNAPSHOT
- TABLE 159.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): OPERATING SEGMENTS
- TABLE 160.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): PRODUCT PORTFOLIO
- TABLE 161.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): NET SALES,
- TABLE 162.DANAHER CORPORATION(CYTIVA LIFE SCIENCES): KEY STRATERGIES
- TABLE 163.ILLUMINA, INC.: COMPANY SNAPSHOT
- TABLE 164.ILLUMINA, INC.: OPERATING SEGMENTS
- TABLE 165.ILLUMINA, INC.: PRODUCT PORTFOLIO
- TABLE 166.ILLUMINA, INC.: NET SALES,
- TABLE 167.ILLUMINA, INC.: KEY STRATERGIES
- TABLE 168.BERKLEY LIGHTS INC: COMPANY SNAPSHOT
- TABLE 169.BERKLEY LIGHTS INC: OPERATING SEGMENTS
- TABLE 170.BERKLEY LIGHTS INC: PRODUCT PORTFOLIO
- TABLE 171.BERKLEY LIGHTS INC: NET SALES,
- TABLE 172.BERKLEY LIGHTS INC: KEY STRATERGIES
- TABLE 173.BGI GENOMICS CO. LTD: COMPANY SNAPSHOT
- TABLE 174.BGI GENOMICS CO. LTD: OPERATING SEGMENTS
- TABLE 175.BGI GENOMICS CO. LTD: PRODUCT PORTFOLIO
- TABLE 176.BGI GENOMICS CO. LTD: NET SALES,
- TABLE 177.BGI GENOMICS CO. LTD: KEY STRATERGIES
- TABLE 178.DIASORIN GROUP (LUMINEX CORPORATION): COMPANY SNAPSHOT
- TABLE 179.DIASORIN GROUP (LUMINEX CORPORATION): OPERATING SEGMENTS
- TABLE 180.DIASORIN GROUP (LUMINEX CORPORATION): PRODUCT PORTFOLIO
- TABLE 181.DIASORIN GROUP (LUMINEX CORPORATION): NET SALES,
- TABLE 182.DIASORIN GROUP (LUMINEX CORPORATION): KEY STRATERGIES
- TABLE 183.DOLOMITE BIO: COMPANY SNAPSHOT
- TABLE 184.DOLOMITE BIO: OPERATING SEGMENTS
- TABLE 185.DOLOMITE BIO: PRODUCT PORTFOLIO
- TABLE 186.DOLOMITE BIO: NET SALES,
- TABLE 187.DOLOMITE BIO: KEY STRATERGIES
- TABLE 188.MERCK KGAA: COMPANY SNAPSHOT
- TABLE 189.MERCK KGAA: OPERATING SEGMENTS
- TABLE 190.MERCK KGAA: PRODUCT PORTFOLIO
- TABLE 191.MERCK KGAA: NET SALES,
- TABLE 192.MERCK KGAA: KEY STRATERGIES
- TABLE 193.OXFORD NANAOPORE TECHNOLOGIES: COMPANY SNAPSHOT
- TABLE 194.OXFORD NANAOPORE TECHNOLOGIES: OPERATING SEGMENTS
- TABLE 195.OXFORD NANAOPORE TECHNOLOGIES: PRODUCT PORTFOLIO
- TABLE 196.OXFORD NANAOPORE TECHNOLOGIES: NET SALES,
- TABLE 197.OXFORD NANAOPORE TECHNOLOGIES: KEY STRATERGIES
- TABLE 198.QIAGEN N.V: COMPANY SNAPSHOT
- TABLE 199.QIAGEN N.V: OPERATING SEGMENTS
- LIST OF FIGURES
- FIGURE 1.SINGLE CELL ANALYSIS MARKET SEGMENTATION
- FIGURE 2.SI
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook